SIGA Technologies

🇮🇳India
Ownership
-
Employees
45
Market Cap
$665.8M
Website
news-journal.com
·

SIGA Launches Process-Oriented OT Cybersecurity Solutions Suite

SIGA launches SigaML², an OT cybersecurity suite with SigaGuardX and S-PAS tools for early alerts, IR, and attack simulation, aiming to address OT cyberattack threats and enhance CISO decision-making.
nypost.com
·

SIGA under investigation after release of NYC's ex-COVID czar's comments on vaccine

Dr. Jay Varma, ex-Covid czar of NYC, is under investigation for allegedly spinning media stories about SIGA Technologies' monkeypox drug TPOXX to protect stock prices. Secret recordings reveal Varma's comments, leading to a 15% drop in SIGA's stock. Varma was fired from SIGA and removed from its board.
mynbc15.com
·

NYC law firm probes pharma company over potential security violations

Wolf Haldenstein Adler Freeman & Herz investigates Siga Technologies for potential securities violations after former NYC COVID czar Jay Varma, who was on Siga’s board, admitted to promoting Siga’s monkeypox drug TPOXX despite low public risk. Varma’s comments aimed to maintain investor confidence, but Siga’s stock dropped 15% post-revelation. Siga fired Varma and distanced itself from his comments, asserting TPOXX’s effectiveness.
nypost.com
·

Jay Varma details in secret recording how to use the media to 'spin' stories about Mpox drug

Dr. Jay Varma, NYC's ex-COVID czar, admits using media to 'spin stories' about a monkeypox drug by former employer SIGA Technologies, aiming for FDA approval.
kfoxtv.com
·

NYC COVID czar reveals he pushed monkeypox drug despite 'very low' risk to public

Jay Varma, former NYC Mayor’s Office Senior Advisor for Public Health, admitted to pushing monkeypox drug TPOXX despite low risk to the general public, focusing on gay men. Varma aimed to get FDA approval for TPOXX, leveraging media to maintain public belief in the drug's efficacy.
© Copyright 2024. All Rights Reserved by MedPath